| Article

Naltrexone implants were shown to significantly improve medication adherence in HIV+ patients with opioid use disorder, according to a recently completed randomized, double-blind, double-dummy trial. The implant releases the medication over a 3-month interval and was found to be superior to daily...

Subscribe to HIV

Sign Up

Subscribe to the PAINWeek Newsletter
and get our latest articles and more directly in your inbox.